These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
756 related articles for article (PubMed ID: 26633741)
1. pH and Glutathione Dual-Responsive Dynamic Cross-Linked Supramolecular Network on Mesoporous Silica Nanoparticles for Controlled Anticancer Drug Release. Li QL; Xu SH; Zhou H; Wang X; Dong B; Gao H; Tang J; Yang YW ACS Appl Mater Interfaces; 2015 Dec; 7(51):28656-64. PubMed ID: 26633741 [TBL] [Abstract][Full Text] [Related]
2. Superparamagnetic Reduction/pH/Temperature Multistimuli-Responsive Nanoparticles for Targeted and Controlled Antitumor Drug Delivery. Zeng J; Du P; Liu L; Li J; Tian K; Jia X; Zhao X; Liu P Mol Pharm; 2015 Dec; 12(12):4188-99. PubMed ID: 26554495 [TBL] [Abstract][Full Text] [Related]
3. pH and Ultrasound Dual-Responsive Polydopamine-Coated Mesoporous Silica Nanoparticles for Controlled Drug Delivery. Li X; Xie C; Xia H; Wang Z Langmuir; 2018 Aug; 34(34):9974-9981. PubMed ID: 30056720 [TBL] [Abstract][Full Text] [Related]
4. Glutathione- and pH-responsive nonporous silica prodrug nanoparticles for controlled release and cancer therapy. Xu Z; Liu S; Kang Y; Wang M Nanoscale; 2015 Mar; 7(13):5859-68. PubMed ID: 25757484 [TBL] [Abstract][Full Text] [Related]
5. Mesoporous silica nanoparticles combining Au particles as glutathione and pH dual-sensitive nanocarriers for doxorubicin. Xu S; Li Y; Chen Z; Hou C; Chen T; Xu Z; Zhang X; Zhang H Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():258-264. PubMed ID: 26652372 [TBL] [Abstract][Full Text] [Related]
6. Gated mesoporous silica nanoparticles for the controlled delivery of drugs in cancer cells. Giménez C; de la Torre C; Gorbe M; Aznar E; Sancenón F; Murguía JR; Martínez-Máñez R; Marcos MD; Amorós P Langmuir; 2015 Mar; 31(12):3753-62. PubMed ID: 25742160 [TBL] [Abstract][Full Text] [Related]
7. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery. Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830 [TBL] [Abstract][Full Text] [Related]
8. Silica nanotubes decorated by pH-responsive diblock copolymers for controlled drug release. Zhou J; Zhang W; Hong C; Pan C ACS Appl Mater Interfaces; 2015 Feb; 7(6):3618-25. PubMed ID: 25625307 [TBL] [Abstract][Full Text] [Related]
9. In situ monitoring of intracellular controlled drug release from mesoporous silica nanoparticles coated with pH-responsive charge-reversal polymer. Zhang P; Wu T; Kong JL ACS Appl Mater Interfaces; 2014 Oct; 6(20):17446-53. PubMed ID: 25231082 [TBL] [Abstract][Full Text] [Related]
10. The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent. Guo R; Li LL; Zhao WH; Chen YX; Wang XZ; Fang CJ; Feng W; Zhang TL; Ma X; Lu M; Peng SQ; Yan CH Nanoscale; 2012 Jun; 4(11):3577-83. PubMed ID: 22543578 [TBL] [Abstract][Full Text] [Related]
11. Polymer-Coated Hollow Mesoporous Silica Nanoparticles for Triple-Responsive Drug Delivery. Zhang Y; Ang CY; Li M; Tan SY; Qu Q; Luo Z; Zhao Y ACS Appl Mater Interfaces; 2015 Aug; 7(32):18179-87. PubMed ID: 26221866 [TBL] [Abstract][Full Text] [Related]
12. Intracellular pH-Triggered, Targeted Drug Delivery to Cancer Cells by Multifunctional Envelope-Type Mesoporous Silica Nanocontainers. Yang K; Luo H; Zeng M; Jiang Y; Li J; Fu X ACS Appl Mater Interfaces; 2015 Aug; 7(31):17399-407. PubMed ID: 26196506 [TBL] [Abstract][Full Text] [Related]
13. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery. Ma X; Zhao Y; Ng KW; Zhao Y Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533 [TBL] [Abstract][Full Text] [Related]
14. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release. Zheng Q; Lin T; Wu H; Guo L; Ye P; Hao Y; Guo Q; Jiang J; Fu F; Chen G Int J Pharm; 2014 Mar; 463(1):22-6. PubMed ID: 24393764 [TBL] [Abstract][Full Text] [Related]
15. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells. Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912 [TBL] [Abstract][Full Text] [Related]
16. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity. Li J; Du X; Zheng N; Xu L; Xu J; Li S Colloids Surf B Biointerfaces; 2016 May; 141():374-381. PubMed ID: 26878288 [TBL] [Abstract][Full Text] [Related]
17. Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles. Lin JT; Liu ZK; Zhu QL; Rong XH; Liang CL; Wang J; Ma D; Sun J; Wang GH Colloids Surf B Biointerfaces; 2017 Jul; 155():41-50. PubMed ID: 28407530 [TBL] [Abstract][Full Text] [Related]
18. Esterase- and pH-responsive poly(β-amino ester)-capped mesoporous silica nanoparticles for drug delivery. Fernando IR; Ferris DP; Frasconi M; Malin D; Strekalova E; Yilmaz MD; Ambrogio MW; Algaradah MM; Hong MP; Chen X; Nassar MS; Botros YY; Cryns VL; Stoddart JF Nanoscale; 2015 Apr; 7(16):7178-83. PubMed ID: 25820516 [TBL] [Abstract][Full Text] [Related]
19. Aerosol-Assisted Synthesis of Tailor-Made Hollow Mesoporous Silica Microspheres for Controlled Release of Antibacterial and Anticancer Agents. Poostforooshan J; Belbekhouche S; Shaban M; Alphonse V; Habert D; Bousserrhine N; Courty J; Weber AP ACS Appl Mater Interfaces; 2020 Feb; 12(6):6885-6898. PubMed ID: 31967774 [TBL] [Abstract][Full Text] [Related]
20. Ultrasound, pH, and magnetically responsive crown-ether-coated core/shell nanoparticles as drug encapsulation and release systems. Lee SF; Zhu XM; Wang YX; Xuan SH; You Q; Chan WH; Wong CH; Wang F; Yu JC; Cheng CH; Leung KC ACS Appl Mater Interfaces; 2013 Mar; 5(5):1566-74. PubMed ID: 23402574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]